Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Pharmaceutical Care and Text Messaging Intervention to Improve Tuberculosis Care and Management Among Drug-susceptible Patients in Pakistan.

NCT04264221 is registered in ClinicalTrials.gov with Farman Ullah Khan as lead sponsor.

NCT NCT04264221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Pharmaceutical Care and Text Messaging Intervention to Improve Tuberculosis Care and Management Among Drug-susceptible Patients in Pakistan.
Lead sponsor
Farman Ullah Khan
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2020
Completion date
December 1, 2020
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tb